These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19084215)

  • 1. [Prolongation of oral anticoagulant treatment for eighteen months versus placebo at the decline of a first episode of idiopathic pulmonary embolism treated for six months: a randomized, multicentric, double blind trial. 2006 National PHRC (Hospital clinical research programme): "PADIS-EP/Prolongation of anticoagulant treatment for 18 months for a first episode of PE initially treated for 6 months"].
    Couturaud F
    Rev Pneumol Clin; 2008 Dec; 64(6):332-6. PubMed ID: 19084215
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prolongation of anti vitamin K treatment for 18 months versus placebo after 6 months treatment of a first episode of ideopathic pulmonary embolism: a mutlicentre, randomised double blind trail. The PADIS-EP Trial].
    Couturaud F; Pernod G; Pison C; Mismetti P; Sanchez O; Meyer G; Parent F; Girard P; Simonneau G; Drouet L; Gueret P; Jego P; Delaval P; Duhamel E; Gruel Y; Delahousse B; Regina S; Pottier P; Connaud J; Lecomte F; Provost K; Vilmans N; Gosset X; Bura-Rivière A; Meach G; Lacut K; Bosson JL; Guillot K; Mottier D; Leroyer C
    Rev Mal Respir; 2008 Sep; 25(7):885-93. PubMed ID: 18946418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of the first episode of pulmonary embolism in the hospital. Anticoagulants, anti-platelet aggregation drugs and thrombolysis stimulants].
    Moriau M; Lavenne-Pardonge E; Col-De Beys C; Jaumin P; el Gariani A; Rubay J; Goenen M
    Acta Chir Belg; 1986; 86(2):97-105. PubMed ID: 3716728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal initial anticoagulant therapy in pulmonary thromboembolism: randomized trial suggested.
    Koracevic GP
    Am J Emerg Med; 2013 Feb; 31(2):407-9. PubMed ID: 23158609
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current results of hemostasis research (protein C, protein S) and their effect on oral anticoagulant therapy in clinical practice].
    Gruber A; Domján G; Blaskó G; Rákóczi I; Petö I; Sas G
    Orv Hetil; 1985 Nov; 126(45):2759-64. PubMed ID: 2933622
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment standards of the oral anticoagulant in patients with idiopathic pulmonary embolism].
    Kowalski Z; Kowalski P; Grzegorek D
    Pol Merkur Lekarski; 2016 Aug; 41(242):97-100. PubMed ID: 27591448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulant treatment of pulmonary embolism].
    Godal HC
    Tidsskr Nor Laegeforen; 1971 Oct; 91(29):2129-30. PubMed ID: 5130892
    [No Abstract]   [Full Text] [Related]  

  • 9. Systolic heart failure: a prothrombotic state.
    de Peuter OR; Kok WE; Torp-Pedersen C; Büller HR; Kamphuisen PW
    Semin Thromb Hemost; 2009 Jul; 35(5):497-504. PubMed ID: 19739040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical studies with anticoagulants to improve survival in cancer patients.
    Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I
    Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended warfarin treatment after pulmonary embolism.
    Burki TK
    Lancet Respir Med; 2015 Aug; 3(8):606. PubMed ID: 26210314
    [No Abstract]   [Full Text] [Related]  

  • 12. Blazing saddles.
    Webb E
    J Miss State Med Assoc; 2008 Jan; 49(1):7-10. PubMed ID: 19297892
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulmonary embolus in Glanzmann's thrombasthenia treated with warfarin.
    Seretny M; Senadheera N; Miller E; Keeling D
    Haemophilia; 2008 Sep; 14(5):1138-9. PubMed ID: 18624697
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosing pulmonary embolism. Morbidity should be taken into account when deciding on anticoagulant treatment.
    Fitzmaurice D; Murray ET; Hobbs FD
    BMJ; 1997 May; 314(7093):1551. PubMed ID: 9183212
    [No Abstract]   [Full Text] [Related]  

  • 15. [New large-scale studies with idraparinux, a prolonged action anticoagulant active via parenteral administration].
    Samama MM
    J Mal Vasc; 2008 May; 33(2):69-71. PubMed ID: 18513598
    [No Abstract]   [Full Text] [Related]  

  • 16. Painful plaques shortly after hospital discharge. Warfarin plaques.
    Graham JB; Fagan B; Latessa R
    Am Fam Physician; 2008 Mar; 77(5):675-6. PubMed ID: 18350767
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic use of anticoagulants. Psychosocial adaptation.
    Griffith EE; Hero N
    N Y State J Med; 1979 Jan; 79(1):90-2. PubMed ID: 282478
    [No Abstract]   [Full Text] [Related]  

  • 18. [Care of acute pulmonary embolism].
    Gut-Gobert C; Couturaud F; Leroyer C; Sanchez O
    Rev Pneumol Clin; 2008 Dec; 64(6):298-304. PubMed ID: 19084209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic ranges in anticoagulant administration.
    Poller L
    Br Med J (Clin Res Ed); 1985 Jun; 290(6483):1683-6. PubMed ID: 3924215
    [No Abstract]   [Full Text] [Related]  

  • 20. Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery.
    Van Thiel D; Kalodiki E; Wahi R; Litinas E; Haque W; Rao G
    Clin Appl Thromb Hemost; 2009; 15(4):389-94. PubMed ID: 19608550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.